Inflammatory Bowel Disease

Healio Gastroenterology presents the following reports on the most recent research on the intersection of COVID-19 and gastroenterology.

Patients with Crohn’s disease who undergo total hip arthroplasty may be at higher risk of medical complications, longer hospital stays and increased costs of care, according to published results.

A relatively high rate of COVID-19 vaccination intent was observed among inflammatory bowel disease populations; however, long-term safety concerns were common, according to study results.

Researchers developed a wearable sweat sensor that can predict flareups of inflammatory bowel disease. A summary of their findings on the performance of the device was the top story in gastroenterology last week.

Patients with inflammatory bowel disease who also had non-alcoholic fatty liver disease had higher readmission rates, according to research presented at Crohn’s and Colitis Congress.

Physicians should encourage patients with inflammatory bowel disease to get the COVID-19 vaccination despite lack of studies on the cohort, according to a presentation at the Crohn’s and Colitis Congress.

In this exclusive video from Crohn’s and Colitis Congress, Laurie Keefer, PhD, from the Icahn School of Medicine at Mount Sinai, discusses her presentation on subjective wellbeing in patients with IBD.

Study results demonstrate diet may differentially influence the gut microbiome in children with Crohn’s disease, according to a presentation at the Crohn’s and Colitis Congress.

Children with inflammatory bowel disease who receive anti-tumor necrosis factor treatment were more likely to see BMI levels increase and incur a risk for obesity, according to a presentation at Crohn’s and Colitis Congress.

To improve shared decision-making in care for patients with inflammatory bowel disease, the problem of numeracy – both among patients and providers – must be discussed, according to a presentation at Crohn’s and Colitis Congress.